This website is part of the ECDC (European Centre for Disease Prevention and Control) network

Antimicrobial resistance surveillance in Europe 2013

17 Nov 2014
Available as PDF in the following languages
This document is free of charge.
Abstract

​This report presents antimicrobial resistance data for seven microorganisms of major public health importance: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter species, Streptococcus pneumoniae, Staphylococcus aureus, and Enterococci. For 2013, data were reported by 30 countries and the report also presents trend analyses for the period 2010–2013.

Read the summary of the report

EARS-NET - Downloadable data

 

Downloadable data

The above zip folder contains the following tables and maps (available as Microsoft Excel files (.xlsx) and as images (.png)).

Escherichia coli

  • Total number of invasive isolates tested (N) and percentage resistant to aminopenicillins (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Total number of invasive isolates tested (N) and percentage resistant to fluoroquinolones (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates with resistance to fluoroquinolones, by country, EU/EEA countries, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to third-generation cephalosporins (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to third-generation cephalosporins, by country, EU/EEA, 2013
  • Number of reporting laboratories, total numbers of invasive isolates resistant to third-generation cephalosporins (3GCREC) and percentage of these isolates positive for extended-spectrum beta-lactamase (ESBL), as ascertained by the participating laboratories, EU/EEA countries, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to aminoglycosides, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to carbapenems (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to carbapenems, by country, EU/EEA, 2013
  • Total number of isolates tested (N) and percentage combined resistance to fluoroquinolones, third-generation cephalosporins and aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates with combined resistance to third-generation cephlosporins, fluoroquinolone and aminoglycosides, by country, EU/EEA, 2013

Klebsiella pneumoniae

  • Total number of invasive isolates tested (N) and percentage resistant to fluoroquinolones (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to fluoroquinolones, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to third-generation cephalosporins (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to third-generation cephalosporins, by country, EU/EEA, 2013
  • Number of invasive isolates resistant to third-generation cephalosporins (3GCRKP) and percentage of these isolates positive for extended-spectrum beta-lactamase (ESBL), as ascertained by participating laboratories, by country, EU/EEA countries, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to aminoglycosides, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to carbapenems (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to carbapenems, by country, EU/EEA, 2013
  • Total number of isolates tested (N) and percentage of combined resistance to fluoroquinolones, third-generation cephalosporins and aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates with combined resistance to fluoroquinolones, third-generation cephalosporins and carbapenems, by country, EU/EEA, 2013

Pseudomonas auroginosa

  • Total number of invasive isolates tested (N) and percentage resistant to piperacillin (+ tazobactam) (%R), including 95% confidence intervals (95%CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to piperacillin+tazobactam, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to fluoroquinolones (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to fluoroquinolones, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to ceftazidime (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to ceftazidime, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to aminoglycosides, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to carbapenems (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to carbpenems, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) with combined resistance (resistance to three or more antimicrobial groups among piperacillin (+ tazobactam), ceftazidime, fluoroquinolones, aminoglycosides and carbapenems) including 95% confidence intervals (95% CI), by country, EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates with combined resistance (resistance to three or more antimicrobial classes among piperacillin(+tazobactam), ceftazidime, fluoroquinolones, aminoglycosides and carbapenems), by country, EU/EEA, 2013


Acinetobacter spp

  • Total number of invasive isolates tested (N) and percentage resistant to fluoroquinolones (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2012-2013
  • Percentage (%) of invasive isolates resistant to fluoroquinolones, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2012-2013
  • Percentage (%) of invasive isolates resistant to aminoglycosides, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to carbapenems (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2012-2013
  • Percentage (%) of invasive isolates resistant to carbapenems, by country, EU/EEA, 2013
  • Total number of isolates tested (N) and percentage combined resistance to fluoroquinolones, aminoglycosides and carbapenems (%R), including 95% confidence intervals (95% CI), by country, EU/EEA countries, 2012-2013
  • Percentage (%) of invasive isolates with combined resistance to fluoroquinolones, aminoglycosides and carbapenems , by country, EU/EEA, 2013

 

Streptococcus pneumoniae

  • Total number of tested isolates (N) and percentages non-susceptible to penicillin (%IR), including 95% confidence intervals (95% CI), by country, EU/EEA countries, 2010-2013
  • Total number of tested isolates (N) and percentages non-susceptible to macrolides (%IR), including 95% confidence intervals (95% CI), by country, EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates non-susceptible to macrolides, by country, EU/EEA, 2013
  • Total number of tested isolates (N) and percentages non-susceptible to penicillins and macrolides (%IR), including 95% confidence intervals (95% CI), by country, EU/EEA countries, 2010-2013

 

Staphylococcus aureus

  • Total number of invasive isolates tested (N) and percentage resistant to meticillin (MRSA) including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to meticillin (MRSA), by country, EU/EEA, 2013


Enterococci

  • Total number of invasive isolates tested (N) and percentage with high-level resistance to aminoglycosides including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates with high-level resistance to aminoglycosides, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to vancomycin, including 95% confidence intervals (95% CI) EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to vancomycin, by country, EU/EEA, 2013
© European Centre for Disease Prevention and Control (ECDC) 2005 - 2016